Home ›
Trademark Categories ›
Pharmaceuticals ›
2005 ›
TH ›
THYROVIN
Trademark search for:
THYROVIN
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2005-06-10 — Application filed
2005-06-16 — Application filed
2005-12-30 — Approved for pub - principal register
2005-12-30 — Assigned to examiner
2006-01-06 — Assigned to lie
2006-01-12 — Law office publication review completed
2006-02-08 — Notice of publication
2006-02-28 — Published for opposition
2006-05-23 — Noa mailed - sou required from applicant
2006-06-06 — Teas change of correspondence received
2006-11-22 — Sou teas extension received
2006-11-22 — Sou extension 1 filed
2006-11-22 — Sou extension 1 granted
2007-05-11 — Sou teas extension received
2007-05-11 — Sou extension 2 filed
2007-05-11 — Sou extension 2 granted
2007-11-14 — Sou teas extension received
2007-11-14 — Sou extension 3 filed
2007-11-14 — Sou extension 3 granted
2008-05-22 — Sou teas extension received
2008-05-22 — Sou extension 4 granted
2008-05-22 — Sou extension 4 filed
2008-11-14 — Sou teas extension received
2008-11-14 — Sou extension 5 filed
2008-11-14 — Sou extension 5 granted
2009-06-22 — Application abandoned
2009-06-22 — Application abandoned
2009-06-22 — Final status recorded
Owner Information
Direct Management Institute, LLC
Brea , CA
Direct Management Institute, LLC
Brea , CA
Correspondent
Charles H. Knull Ullman, Shapiro & Ullman, LLP 299 Broadway, Suite 1700 New York, NY 10007 UNITED STATES
Filing Details
Filing Date:
2005-06-10
Status Date:
2009-06-22
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.